A peptide formed by fibrinolysis increases microvascular permeability and inhibits angiotensin converting enzyme
Saldeen, T.; Ryan, J.W.; Ragnarsson, U.
Advances in Experimental Medicine and Biology 156: 829-834
1983
ISSN/ISBN: 0065-2598 PMID: 6305169 Document Number: 219741
Document emailed within 1 workday
Related Documents
Gong, J.-j.; Lu, Z.-q.; Cao, J.-l.; Xu, C.-s.; Wang, H.-j.; Jin, X.-q. 2012: Overexpression of angiotensin-converting enzyme 2 inhibits angiotensin Ii type 1 receptor expression and signal transducer and activator of transcription 3 phosphorylation in cultured smooth muscle cells Zhonghua Xin Xue Guan Bing Za Zhi 40(7): 607-613Andert, S.E.; Feichtinger, E.; Grabenwöger, M.; Grimm, M.; Schreiner, W.; Müller, M.M. 1993: Cyclosporine a increases angiotensin-converting enzyme activity in heart transplant patients Transplantation Proceedings 25(4): 2735-2737
Schlotfeldt, D.; Nowak, B.; Weist, P. 1992: Procollagen III-peptide and angiotensin converting enzyme in bronchoalveolar lavage in sarcoidosis Pneumologie 46(3): 101-106
Kobayashi, T.; Miyauchi, T.; Sakai, S.; Yamaguchi, I.; Goto, K.; Sugishita, Y. 1998: Endothelin-converting enzyme and angiotensin-converting enzyme in failing hearts of rats with myocardial infarction Journal of Cardiovascular Pharmacology 31(Suppl): S417-S420
Zou, K.; Michikawa, M.; Komano, H. 2010: Novel Abeta-converting activity of angiotensin-converting enzyme and its role in Alzheimer's disease Seikagaku. Journal of Japanese Biochemical Society 82(12): 1120-1124
Ganten, D.; Mullins, J.; Lindpaintner, K. 1989: The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors Journal of Human Hypertension 3(Suppl 1): 63-70
Aurell, M. 1984: Physiological aspects of the renin-angiotensin system and peroral angiotensin converting enzyme inhibition Scandinavian Journal of Urology and Nephrology. Supplementum 79: 9-12
Novo, S.; Adamo, L.; Giamporcaro, A.; Forte, G.; Longo, B.; Gallo, V.B.; Licata, G.; Strano, A. 1987: Changes of angiotensin converting enzyme (ACE) levels during activation of the renin-angiotensin-aldosterone system (RAAs) Agents and Actions. Supplements 22: 339-347
De Paz, S.; Martín, A.B.; Iglesias, A.; Domínguez, A.R. 1999: Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin Ii receptor antagonists Medicina Clinica 113(19): 759
Haznedaroğlu, I.C. 1997: Angiotensin I-converting enzyme, blood groups, and a local marrow-specific renin-angiotensin system Experimental Hematology 25(2): 93
Jover, B.; Mimran, A. 1994: Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(9): S3-S9
Krzesinski, J.M.; Montrieux, C.; Scheen, A.J. 2006: Angiotensin converting enzyme inhibitors or angiotensin Ii receptor blocker in cardiovascular and renal pathology in 2006: what does EBM teach us? Revue Medicale de Liege 61(5-6): 414-422
Santucci, A.; Aguglia, F.; De Mattia, G.; Cammarella, I.; Trinchieri, F.; Giordano, M.; Gnecchi, M.; Ficara, C. 1983: Role of the renin-angiotensin-aldosterone system in ascitic hepatic cirrhosis. Effects of inhibition of angiotensin i converting enzyme La Clinica Terapeutica 106(2): 121-124
Anantharaman, R.; Bhansali, A.; Bhadada, S.K.; Kohli, H.S.; Dutta, P.; Walia, R.; Jayaprakash, P.; Upreti, V. 2010: Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor and angiotensin receptor blocker in type 1 DM with nephropathy Indian Journal of Medical Research 132: 42-47
Iimura, O.; Kusano, E.; Tanba, K.; Yanagiba, S.; Amemiya, M.; Ando, Y.; Honma, S.; Muto, S.; Asano, Y. 2003: Additive antiproteinuric effect of angiotensin Ii receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis Nihon Jinzo Gakkai Shi 45(5): 439-444
Surabenjawong, U.; Thunpiphat, N.; Chatsiricharoenkul, S.; Monsomboon, A. 2013: Prevalence of hyperkalemia in adult patients taking spironolactone and angiotensin converting enzyme inhibitors or angiotensin receptor blockers Journal of the Medical Association of Thailand 96(8): 905-910
Kono, T.; Ikeda, F.; Oseko, F.; Imura, H.; Endo, J. 1978: Angiotensin i converting enzyme inhibitor and angiotensin Ii antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 36(11): 3613-3620
Xiao, H.D.; Fuchs, S.; Frenzel, K.; Teng, L.; Bernstein, K.E. 2004: Circulating versus local angiotensin II in blood pressure control: lessons from tissue-specific expression of angiotensin-converting enzyme (ACE) Critical Reviews in Eukaryotic Gene Expression 14(1-2): 137-145
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin converting enzyme inhibitors and angiotensin Ii receptor blockers on angiogenesis of gastric cancer in a nude mouse model Zhonghua Wei Chang Wai Ke Za Zhi 11(6): 565-568
Benetos, A.; Gautier, S.; Ricard, S.; Topouchian, J.; Asmar, R.; Poirier, O.; Larosa, E.; Guize, L.; Safar, M.; Soubrier, F.; Cambien, F. 1996: Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients Circulation 94(4): 698-703